• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病理性矿化的决定因素。

Determinants of pathological mineralization.

作者信息

Kirsch Thorsten

机构信息

Musculoskeletal Research Laboratories, Department of Orthopaedics, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.

出版信息

Curr Opin Rheumatol. 2006 Mar;18(2):174-80. doi: 10.1097/01.bor.0000209431.59226.46.

DOI:10.1097/01.bor.0000209431.59226.46
PMID:16462525
Abstract

PURPOSE OF REVIEW

Physiological mineralization is necessary for the formation of skeletal tissues and for their appropriate functions during adulthood. Pathological or ectopic mineralization of soft tissues, including articular cartilage and cardiovascular tissues, leads to morbidity and mortality. Recent findings suggest that the mechanisms and factors regulating physiological mineralization may be identical or similar to those regulating ectopic mineralization. Therefore, the purpose of this review is to describe the current knowledge of mechanisms and determinants that regulate physiological mineralization and how these determinants can be used to understand ectopic mineralization better.

RECENT FINDINGS

Recent findings have indicated that physiological and pathological mineralization are initiated by matrix vesicles, membrane-enclosed particles released from the plasma membrane of mineralization-competent cells. An understanding of how these vesicles initiate the physiological mineralization process may provide novel therapeutic strategies to prevent ectopic mineralization. In addition, other regulators (activators and inhibitors) of physiological mineralization have been identified and characterized, and evidence indicates that the same factors also contribute to the regulation of ectopic mineralization. Finally, programmed cell death (apoptosis) may be a contributor to physiological mineralization, and if occurring after tissue injury may induce ectopic mineralization and mineralization-related differentiation events in the injured area and surrounding areas.

SUMMARY

This review describes how the understanding of mechanisms and factors regulating physiological mineralization can be used to develop new therapeutic strategies to prevent pathological or ectopic mineralization events.

摘要

综述目的

生理性矿化对于骨骼组织的形成及其在成年期的正常功能至关重要。包括关节软骨和心血管组织在内的软组织发生病理性或异位矿化会导致发病和死亡。最近的研究结果表明,调节生理性矿化的机制和因素可能与调节异位矿化的机制和因素相同或相似。因此,本综述的目的是描述目前关于调节生理性矿化的机制和决定因素的知识,以及如何利用这些决定因素更好地理解异位矿化。

最新发现

最近的研究结果表明,生理性和病理性矿化均由基质小泡引发,基质小泡是具有矿化能力的细胞的质膜释放的膜包被颗粒。了解这些小泡如何启动生理性矿化过程可能会为预防异位矿化提供新的治疗策略。此外,已鉴定并表征了生理性矿化的其他调节因子(激活剂和抑制剂),有证据表明相同的因素也参与异位矿化的调节。最后,程序性细胞死亡(凋亡)可能是生理性矿化的一个促成因素,如果在组织损伤后发生,可能会在损伤区域及其周围诱导异位矿化和矿化相关的分化事件。

总结

本综述描述了如何利用对调节生理性矿化的机制和因素的理解来开发新的治疗策略,以预防病理性或异位矿化事件。

相似文献

1
Determinants of pathological mineralization.病理性矿化的决定因素。
Curr Opin Rheumatol. 2006 Mar;18(2):174-80. doi: 10.1097/01.bor.0000209431.59226.46.
2
Determinants of pathologic mineralization.
Crit Rev Eukaryot Gene Expr. 2008;18(1):1-9. doi: 10.1615/critreveukargeneexpr.v18.i1.10.
3
Molecular determinants of extracellular matrix mineralization in bone and blood vessels.骨与血管细胞外基质矿化的分子决定因素
Curr Opin Nephrol Hypertens. 2010 Jul;19(4):359-65. doi: 10.1097/MNH.0b013e3283393a2b.
4
Biomineralization--an active or passive process?生物矿化——主动过程还是被动过程?
Connect Tissue Res. 2012;53(6):438-45. doi: 10.3109/03008207.2012.730081.
5
The vascular biology of calcification.钙化的血管生物学
Semin Dial. 2007 Mar-Apr;20(2):103-9. doi: 10.1111/j.1525-139X.2007.00255.x.
6
What triggers cell-mediated mineralization?
Front Biosci. 2007 Jan 1;12:2631-45. doi: 10.2741/2260.
7
Mineralization by matrix vesicles.基质小泡介导的矿化作用。
Scan Electron Microsc. 1984(Pt 2):953-64.
8
Normal and abnormal mineralization in mammals.哺乳动物的正常矿化与异常矿化。
Trans Am Soc Artif Intern Organs. 1981;27:702-8.
9
Extracellular matrix calcification in chronic kidney disease.慢性肾脏病中的细胞外基质钙化。
Curr Opin Nephrol Hypertens. 2011 Jul;20(4):360-8. doi: 10.1097/MNH.0b013e3283479330.
10
Proteome analysis of matrix vesicles isolated from femurs of chicken embryo.从鸡胚股骨中分离出的基质小泡的蛋白质组分析。
Proteomics. 2008 Jan;8(1):192-205. doi: 10.1002/pmic.200700612.

引用本文的文献

1
Ultrastructural Aspects of Physiological Mineralization: A Comparative Study in Different Hard Tissues.生理性矿化的超微结构特征:不同硬组织的比较研究
Biomolecules. 2025 Jun 26;15(7):932. doi: 10.3390/biom15070932.
2
Phosphate in Physiological and Pathological Mineralization: Important yet Often Unheeded.磷酸盐在生理和病理矿化中的作用:重要却常被忽视。
MedComm (2020). 2025 Jul 13;6(7):e70298. doi: 10.1002/mco2.70298. eCollection 2025 Jul.
3
Mechanism of influence of calcified nanoparticles in the development of calcified diseases (Review).
钙化纳米颗粒在钙化性疾病发生发展中的影响机制(综述)
Biomed Rep. 2025 Apr 22;22(6):102. doi: 10.3892/br.2025.1980. eCollection 2025 Jun.
4
Changes in local mineral homeostasis facilitate the formation of benign and malignant testicular microcalcifications.局部矿物质稳态的变化促进良性和恶性睾丸微钙化的形成。
Elife. 2025 Apr 25;13:RP95545. doi: 10.7554/eLife.95545.
5
Influence of clinical experience in detecting calcifications of the head and neck region on panoramic radiographs: an app-based evaluation.临床经验对全景X线片上头颈部钙化灶检测的影响:基于应用程序的评估
Ann Med Surg (Lond). 2024 Oct 11;86(11):6447-6454. doi: 10.1097/MS9.0000000000002638. eCollection 2024 Nov.
6
Latest Advances in Chondrocyte-Based Cartilage Repair.基于软骨细胞的软骨修复最新进展
Biomedicines. 2024 Jun 19;12(6):1367. doi: 10.3390/biomedicines12061367.
7
Identification of biological components for sialolith formation organized in circular multi-layers.鉴定以环状多层形式排列的涎石形成的生物组成成分。
Sci Rep. 2023 Jul 28;13(1):12277. doi: 10.1038/s41598-023-37462-w.
8
Contributions of SGK3 to transporter-related diseases.血清糖皮质激素调节激酶3(SGK3)在转运体相关疾病中的作用。
Front Cell Dev Biol. 2022 Dec 1;10:1007924. doi: 10.3389/fcell.2022.1007924. eCollection 2022.
9
The hEag1 K Channel Inhibitor Astemizole Stimulates Ca Deposition in SaOS-2 and MG-63 Osteosarcoma Cultures.依巴斯汀(一种 hEag1 K 通道抑制剂)可刺激 SaOS-2 和 MG-63 骨肉瘤细胞的钙沉积。
Int J Mol Sci. 2022 Sep 11;23(18):10533. doi: 10.3390/ijms231810533.
10
Mineral Crystal Thickness in Calcified Cartilage and Subchondral Bone in Healthy and Osteoarthritic Human Knees.健康及骨关节炎人膝关节中钙化软骨和软骨下骨的矿物晶体厚度。
J Bone Miner Res. 2022 Sep;37(9):1700-1710. doi: 10.1002/jbmr.4642. Epub 2022 Aug 1.